Related Experiment Videos
Prostaglandin D2 inhibits fibroblast migration
1Pulmonary and Critical Care Medicine Section, University of Nebraska Medical Centre, Omaha 68198-5125, USA.
The European Respiratory Journal
|May 10, 2002
Summary
Prostaglandin D2 (PGD2) inhibits human lung fibroblast (HFL-1) migration. This finding suggests PGD2 may regulate wound healing, particularly in asthma patients, by modulating fibroblast chemotaxis.
Area of Science:
- Cell Biology
- Immunology
- Respiratory Medicine
Background:
- Fibroblasts are crucial for tissue repair and remodeling post-injury.
- Prostaglandin D2 (PGD2) is a significant mediator in inflammatory responses.
Purpose of the Study:
- To investigate the effect of PGD2 on human fetal lung fibroblast (HFL-1) chemotaxis.
- To explore the role of PGD2 in fibronectin-induced fibroblast migration.
Main Methods:
- Utilized the blind-well chamber technique to assess HFL-1 cell migration.
- Employed checkerboard analysis to differentiate between chemotaxis and chemokinesis.
- Investigated the involvement of DP receptors, cAMP, and PKA pathways using specific agonists and antagonists.
Main Results:
- PGD2 significantly inhibited HFL-1 chemotaxis and chemokinesis induced by human plasma fibronectin (HFn).
- The inhibitory effect of PGD2 was concentration-dependent and diminished over time.
- DP receptor agonist BW245C mimicked PGD2's inhibitory effect, which was blocked by DP antagonist AH6809, indicating DP receptor mediation.
- The PKA inhibitor KT5720 blocked PGD2's effect, suggesting a cAMP-dependent mechanism mediated by PKA.
Conclusions:
- PGD2 inhibits fibroblast chemotaxis, likely by modulating migration rates via a DP receptor-initiated, cAMP/PKA-dependent pathway.
- This PGD2-mediated inhibition of fibroblast migration may play a role in regulating wound healing processes, potentially impacting conditions like asthma.